[131I] Actuximab

碘[131I]爱克妥昔单抗

Report date: 2025/10/20 14:43:48

Base Information

Drug Name[131I] Actuximab

Drug Alias Name[131I] AiketuoxiIketuximab I-131131I-Aiketuoxi Monoclonal AntibodyDK-001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Iodine > 131I +[4]

Mechanisms of ActionCarcinoembryonic antigen inhibitors

TargetsCarcinoembryonic antigen

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesShanghai Haikang Pharmaceutical Tech &Deve Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Haikang Pharmaceutical Tech &Deve Co Ltd

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A